• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[别嘌醇与苯溴马隆单一及联合治疗。肾脏对致石物质和胶体保护物质的排泄(作者译)]

[Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].

作者信息

Mertz D P

出版信息

Med Klin. 1977 Apr 15;72(15):664-8.

PMID:857138
Abstract

12 hyperuremic male patients got during two comparative tests for 16 days 300 mg/die Allopurinol or 100 mg/die Benzbromarone or a combination of 100 mg Allopurinol with 20 mg Benzbromarone. During this time the renal elimination of uric acid, sodium, calcium, magnesium and citrate war measured and the renal clearance of uric acid, creatinine and sodium was determinated. Without any therapy the combination of 100 mg Allopurinol with 20 mg Benzbromarone per die reduces the elimination of uric acid significantly under the original value in the 24-hour-urine. The elimination of the uric acid increases with 300 mg/die Allopurinol. The clearance ratio of uric acid and creatinine rises 33% to 60%. With 100 mg/die Benzbromarone this value goes up to 233% compared with the results without therapy. At the same time the therapy with Brenzbromarone makes the clearance ratio of uric acid to sodium rise significantly to 257%. Under the 3 types of therapy there is no significant change in the 24-hours-urine of the clearance of creatinine and sodium, the clearance ratio of sodium to creatinine and the elimination ratio of sodium, calcium, magnesium and citrate. Hyperuremic patients with urolithic diathesis need Allopurinol therapy without any combination.

摘要

12名男性尿毒症患者在两项对比试验中,连续16天每天服用300毫克别嘌醇、或100毫克苯溴马隆、或100毫克别嘌醇与20毫克苯溴马隆的组合。在此期间,测量了尿酸、钠、钙、镁和柠檬酸盐的肾脏排泄情况,并测定了尿酸、肌酐和钠的肾脏清除率。在未进行任何治疗的情况下,每天服用100毫克别嘌醇与20毫克苯溴马隆的组合可使24小时尿液中尿酸的排泄量显著低于初始值。每天服用300毫克别嘌醇可使尿酸排泄量增加。尿酸与肌酐的清除率比值上升33%至60%。与未治疗的结果相比,每天服用100毫克苯溴马隆时,该值升至233%。同时,苯溴马隆治疗可使尿酸与钠的清除率比值显著升至257%。在这三种治疗方式下,24小时尿液中肌酐和钠的清除率、钠与肌酐的清除率比值以及钠、钙、镁和柠檬酸盐的排泄率均无显著变化。患有尿路结石素质的尿毒症患者需要单独使用别嘌醇治疗。

相似文献

1
[Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].[别嘌醇与苯溴马隆单一及联合治疗。肾脏对致石物质和胶体保护物质的排泄(作者译)]
Med Klin. 1977 Apr 15;72(15):664-8.
2
[The effect of benzbromaron in gout patients with limited kidney function].
Fortschr Med. 1979 Nov 22;97(44):2057-61.
3
[Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].别嘌醇与苯溴马隆联合治疗高尿酸血症(作者译)
Dtsch Med Wochenschr. 1976 Oct 22;101(43):1568-70. doi: 10.1055/s-0028-1104304.
4
Benzbromarone therapy in management of refractory gout.苯溴马隆治疗难治性痛风
N Z Med J. 2005 Jun 24;118(1217):U1528.
5
[The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].苯溴马隆泡腾颗粒与别嘌醇降尿酸作用的比较研究(作者译)
MMW Munch Med Wochenschr. 1978 Oct 20;120(42):1387-90.
6
[Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
Dtsch Med Wochenschr. 1976 Aug 27;101(35):1288-92. doi: 10.1055/s-0028-1104258.
7
[Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
Fortschr Med. 1976 Sep 16;94(26):1427-9.
8
Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol?治疗剂量的苯溴马隆是否会提高氧嘌呤醇的肾脏排泄量?
Klin Wochenschr. 1984 Dec 17;62(24):1170-2. doi: 10.1007/BF01712184.
9
[Prevention of urinary calculi by means of a benzbromarone-citrate combination].
Fortschr Med. 1980 Nov 27;98(44):1752-5.
10
[Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].[低剂量降尿酸药物对高尿酸血症合并高甘油三酯血症患者的随机分组研究效应]
Fortschr Med. 1979 Jul 19;97(27):1212-4.

引用本文的文献

1
Uricosuric medications for chronic gout.用于慢性痛风的促尿酸排泄药物。
Cochrane Database Syst Rev. 2014 Nov 14;2014(11):CD010457. doi: 10.1002/14651858.CD010457.pub2.